Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity.
about
Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Preclinical comparison of prot ...... s of differential sensitivity.
@en
Preclinical comparison of prot ...... s of differential sensitivity.
@nl
type
label
Preclinical comparison of prot ...... s of differential sensitivity.
@en
Preclinical comparison of prot ...... s of differential sensitivity.
@nl
prefLabel
Preclinical comparison of prot ...... s of differential sensitivity.
@en
Preclinical comparison of prot ...... s of differential sensitivity.
@nl
P2093
P2860
P356
P1433
P1476
Preclinical comparison of prot ...... ms of differential sensitivity
@en
P2093
Andrew P South
Angela McHugh
Irene M Leigh
Jemima E Mellerio
Julio C Salas-Alanís
Kenneth Fernandes
Mark K Saville
P2860
P304
20265-20281
P356
10.18632/ONCOTARGET.24750
P407
P50
P577
2018-04-17T00:00:00Z